Pathogenicity and protective activity in pregnant goats of a Brucella melitensis Deltaomp25 deletion mutant

M D Edmonds1, A Cloeckaert, S D Hagius

  • 1Department of Veterinary Microbiology and Parasitology, School of Veterinary Medicine, Louisiana State University, Baton Rouge, LA 70803, USA.

Insights

The Brucella melitensis Deltaomp25 mutant BM 25 shows promise as a safe and effective vaccine candidate for goats. It colonizes goats without causing abortions and protects them from virulent Brucella melitensis.

Area of Science:

  • Veterinary Microbiology
  • Immunology

Background:

  • Brucellosis is a significant zoonotic disease affecting livestock, particularly goats.
  • Brucella melitensis is a primary cause of caprine brucellosis, leading to abortions and economic losses.
  • Current vaccines may have limitations in specific host populations.

Purpose of the Study:

  • To evaluate the pathogenicity and vaccine potential of the Brucella melitensis Deltaomp25 mutant (BM 25) in goats.
  • To compare the efficacy of BM 25 against the virulent B. melitensis 16M strain and the current vaccine strain Rev. 1.

Main Methods:

  • Infection of pregnant and non-pregnant goats with B. melitensis BM 25 and 16M strains.
  • Assessment of abortion rates, colonization levels in adults and kids, and transient colonization in non-pregnant goats.
  • Vaccine efficacy study involving vaccination with BM 25 or Rev. 1, followed by challenge with B. melitensis 16M.

Main Results:

  • The BM 25 mutant did not induce abortions in pregnant goats, unlike the virulent 16M strain.
  • BM 25 showed reduced colonization in adult goats and kids compared to strain 16M.
  • Both BM 25 and Rev. 1 provided 100% protection against abortion following challenge with virulent 16M, with BM 25 not causing abortions.
  • BM 25 demonstrated transient colonization in non-pregnant goats.

Conclusions:

  • The Brucella melitensis Deltaomp25 mutant BM 25 is attenuated in goats, causing no abortions.
  • BM 25 is a safe and efficacious vaccine candidate, offering protection against virulent B. melitensis challenge.
  • BM 25 may be a suitable alternative to strain Rev. 1 for vaccinating goat herds with mixed age and pregnancy status.